🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The LONG-LIFE study is a randomized Phase I, dose-ranging trial designed to...
Status
Not Yet Recruiting
Location
Vail Health Behavioral Health
Start Date
2026-12
Trial ID
NCT07719088
Treatments Being Tested
The purpose of this study is to determine the safety and feasibility of per...
Status
Recruiting
Location
Ghent University Hospital
Start Date
2024-05-21
Trial ID
NCT06378229
Treatments Being Tested
The PEARL Pilot is a phase II open-label trial. Participants will receive a...
Status
Active Not Recruiting
Location
Princess Margaret Cancer Centre
Start Date
2024-06-06
Trial ID
NCT06416085
Treatments Being Tested
The purpose of this research study is to compare an oral dose of psilocybin...
Status
Withdrawn
Location
University of Wisconsin
Start Date
2023-06
Trial ID
NCT05467761
Treatments Being Tested
The purpose of this research study is to investigate the safety and feasibi...
Status
Terminated
Location
University of Wisconsin
Start Date
2023-03-03
Trial ID
NCT05322954
Treatments Being Tested
This is an open-label trial evaluating feasibility, tolerability, safety an...
Status
Recruiting
Location
St. Michael's Hospital, Unity Health Toronto
Start Date
2026-06
Trial ID
NCT06386003
Treatments Being Tested
The goal of this pilot clinical trial is to learn whether it is feasible to...
Status
Not Yet Recruiting
Location
Jewish General Hospital
Start Date
2026-05
Trial ID
NCT07373535
The primary objective of the study is to evaluate the safety and efficacy o...
Status
Completed
Location
University of Chicago
Start Date
2023-11-01
Trial ID
NCT05399498
Treatments Being Tested
A Phase 2, Open-Label Study to explore the efficacy, safety, and tolerabili...
Status
Recruiting
Location
Sunstone Medical, PC
Start Date
2026-05-23
Trial ID
NCT06902974
Treatments Being Tested
The purpose of this study is to assess brain activity under Psilocybin in a...
Status
Unknown
Location
Imperial College London
Start Date
2022-08-15
Trial ID
NCT05548075
Treatments Being Tested